IMMUNOABLATIVE THERAPIEN

European patent · EP3860612 · In force

Register entry

Publication number
EP3860612
Application number
EP19786713
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 3, 2019
Published
Aug 11, 2021
Granted
Mar 4, 2026
Protection ends at the latest
Oct 2, 2039
Next annual fee due
Oct 31, 2026
IPC classes
A61K 31/573 (2006.01)
A61P 37/06 (2006.01)
Priority
EP 18198491 03.10.2018
PCT application
PCT/US2019/054395 03.10.2019
PCT publication
WO2020/072713 09.04.2020
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 15, 2026

    Agent entered

    Representative
    MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex

    Published in Swissreg on 15.05.2026

  2. Mar 4, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 04.03.2026

Parties

Holder

AVM Biotechnology, LLC

1749 Dexter Ave North, Seattle, WA 98109, US

Agent

MICHELI & CIE SA

122, rue de Genève, CP 61, 1226 Thônex

Inventor

DEISHER, Theresa

Seattle, Washington 98109, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.